ArticleResearch and practice in thrombosis and haemostasis2026
Recurrent venous thromboembolism: association with thrombin generation and d-dimer.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In patients with a first event of venous thromboembolism (VTE) clinicians must decide when to stop anticoagulation, evaluating the risk of recurrent thrombosis. Objectives: The aim of this study was to evaluate the association between recurrent VTE and d-dimer and thrombin generation. Methods: Analyses were performed in 1895 individuals of the Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis (MEGA) case-control study, followed up for recurrent VTE. The cumulative incidence of recurrent VTE, incidence rates, and hazard ratios were estimated by Cox proportional hazard regression models, to obtain rates and risks of VTE for different levels of d-dimer and thrombin generation. Results: Three classes of risk of recurrent VTE were shown: low risk for patients with low d-dimer and thrombin generation (incidence rate, 1.20/100 patient years; 95% confidence interval [CI], 0.75-1.62), intermediate risk for patients with either high d-dimer and low thrombin generation (2.31; 95% CI, 1.97-2.66) or low d-dimer and high thrombin generation (2.89; 95% CI, 0.06-5.73), and high risk for patients with high d-dimer and thrombin generation (4.70; 95% CI, 3.31-6.09).In the subgroup of patients with unprovoked VTE ( Conclusions: The combination of these 2 tests allows identification of patients with high risk of recurrent VTE who could benefit from long-term anticoagulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.